by Jackie (née Heneghan) Peck | Jul 31, 2017 | Blog, Brexit
Cries for “QOFXIT” are being heard from the Government and BMA in the same way as people called for Brexit. There is of course a lot of people who would agree, but it would be good to see as full risk assessment of the pros and cons if we have a QOFXIT and a detailed...
by Jackie (née Heneghan) Peck | Jul 24, 2017 | Blog
The Nuffield Council on Bioethics recommends that dermal fillers become prescription only. This would mean that they would not be able to be advertised in line with other prescription only medicines. Currently many prescribers order their fillers on prescription,...
by Jackie (née Heneghan) Peck | Jul 24, 2017 | Blog
The MHRA have been issuing majors to pharmaceutical wholesalers for several years if they do not have a backup procedure and there is no evidence of it being tested. Loss of data may result in a critical finding if it cannot be produced during an inspection. Why do...
by Jackie (née Heneghan) Peck | Jul 24, 2017 | Blog
Is the software embedded in your medical equipment vulnerable to a cyberattack? Equipment running older software is much more vulnerable to cyberattack. Older software may be embedded in medical devices and may require regular updates. Find out if it is possible?...
by Jackie (née Heneghan) Peck | Jun 21, 2017 | Blog, Export Training, Training
Seven useful terms: “IATA” “The International Air Transport Association “this body regulates air travel worldwide. IATA are responsible for security and safety of air travel and the regulation of air transport of dangerous goods. “CEIV “Centre of Excellence for...
by Jackie (née Heneghan) Peck | Jun 21, 2017 | Blog, Consultancy
Quality Management Systems (QMS) for Wholesalers can be built by a consultant alone, but the best QMS is one which has input from the Company, the staff who carry out the activities and the managers who are responsible for the business and specific processes within...
by Jackie (née Heneghan) Peck | Jun 12, 2017 | Brexit, NHS
The EU market accounts for 25% of all global medicines sales, when we break away and become a smaller separate market, companies may very well priorities bigger markets to introduce their medicines into over the UK. The NHS may as a result struggle to access...
by Jackie (née Heneghan) Peck | May 23, 2017 | Blog, Brexit, Good Distribution Practice - GDP, WDA(H)
The UK triggered Article 50 of the Treaty on European Union on 29th of March 2017 and as a result all primary and secondary law ceases to apply to the UK from 30th of March 2019. Companies who hold centrally authorised “MA s” must proactively review their MA terms,...
by Jackie (née Heneghan) Peck | May 15, 2017 | Blog
I read with interest that the largest suppliers of PGDs has folded with immediate effect. They have trained over 2000 people, and issued certificates of PGD service provision. This is begging the question why? Have they fallen fowl of CQC? Have they gone into...
by Jackie (née Heneghan) Peck | May 12, 2017 | Blog, Consultancy, External Audit, Good Distribution Practice - GDP, Licence Acquisition, MHRA, Regulation, RP, WDA(H), WDA(H)
Do what I say not what I do, how many of us heard this from our parents & teachers or at least thought that it was one of their mottos? Unfortunately this seems to be a common theme in interactions with all sorts of official bodies as well, now I am not daft...
